Dendritic cell immunoreceptor 2 (DCIR2) deficiency decreases hepatic conventional dendritic cell content but not the progression of diet‐induced obesity
Immunity, Inflammation and Disease · 2023
DOI: 10.1002/iid3.1024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2023. Verfasst von Rossella Bellini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Excellence of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy. Hauptthemen laut MEDLINE: Insulins, Obesity. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Telethon.
Abstract (Originalsprache)
Aims
Inflammatory pathways and immune system dysregulation participate in the onset and progression of cardiometabolic diseases. The dendritic cell immunoreceptor 2 (DCIR2) is a C‐type lectin receptor mainly expressed by conventional type 2 dendritic cells, involved in antigen recognition and in the modulation of T cell response. Here, we investigated the effect of DCIR2 deficiency during the development of obesity.
Methods
DCIR2 KO mice and the WT counterpart were fed with high‐fat diet (HFD) for 20 weeks. Weight gain, glucose and insulin tolerance were assessed, parallel to immune cell subset profiling and histological analysis.
Results
After HFD feeding, DCIR2 KO mice presented altered conventional dendritic cell distribution within the liver without affecting markers of hepatic inflammation. These observations were liver restricted, since immune profile of metabolic and lymphoid organs‐namely adipose tissue, spleen and mesenteric lymph nodes‐did not show differences between the two groups. This reflected in a similar metabolic profile of DCIR2 KO compared to WT mice, characterized by comparable body weight gain as well as adipose tissues, spleen, Peyer's patches and mesenteric lymph nodes weight at sacrifice. Also, insulin response was similar in both groups.
Conclusion
Our data show that DCIR2 has a redundant role in the progression of diet‐induced obesity and inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Excellence of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy.
ORCID-Profile: Rossella Bellini, Annalisa Moregola, Jasmine Nour, Patrizia Uboldi, Fabrizia Bonacina, Giuseppe D Norata
Förderung
- Fondazione Telethon
Zitieren
APA
Bellini, R., Moregola, A., Nour, J., Uboldi, P., Bonacina, F., & Norata, G. D. (2023). Dendritic cell immunoreceptor 2 (DCIR2) deficiency decreases hepatic conventional dendritic cell content but not the progression of diet‐induced obesity. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1024
Vancouver
Bellini R, Moregola A, Nour J, Uboldi P, Bonacina F, Norata GD. Dendritic cell immunoreceptor 2 (DCIR2) deficiency decreases hepatic conventional dendritic cell content but not the progression of diet‐induced obesity. Immunity, Inflammation and Disease. 2023. doi:10.1002/iid3.1024
BibTeX
@article{Bellini2023,
author = {Bellini, Rossella and Moregola, Annalisa and Nour, Jasmine and Uboldi, Patrizia and Bonacina, Fabrizia and Norata, Giuseppe D},
title = {Dendritic cell immunoreceptor 2 (DCIR2) deficiency decreases hepatic conventional dendritic cell content but not the progression of diet‐induced obesity},
journal = {Immunity, Inflammation and Disease},
year = {2023},
doi = {10.1002/iid3.1024}
}
EUVIMED